SCHEMBL7384334

SCHEMBL7384334

CC(=O)Nc1ccc(-c2cc3[nH]c(=O)[nH]c3nc2C)cc1

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE3B Q13370 7/20 0.64
PDE3A Q14432 7/20 0.64
XDH P47989 1/20 0.47
ADORA2A P29274 1/20 0.46
ADORA1 P30542 1/20 0.46
KDM4E B2RXH2 4/20 0.46
ALDH1A1 P00352 4/20 0.46
MEN1 O00255 3/20 0.46
HPGD P15428 3/20 0.46
KMT2A Q03164 3/20 0.46
MAPT P10636 3/20 0.46
RXFP1 Q9HBX9 1/20 0.46
SMN1; SMN2 Q16637 3/20 0.45
TP53 P04637 3/20 0.45
HSD17B10 Q99714 3/20 0.45
RAB9A P51151 2/20 0.45
TDP1 Q9NUW8 2/20 0.45
POLB P06746 2/20 0.45
BLM P54132 1/20 0.45
NPC1 O15118 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7383915 0.85 PDE3B (0.58) PDE3BPDE3AMEN1KMT2AMAPT
SCHEMBL7383419 0.84 PDE3B (0.70) PDE3BPDE3A
SCHEMBL7375384 0.83 PDE3B (0.55) PDE3BPDE3AKDM4EMEN1HPGD
SCHEMBL7382710 0.83 PDE3B (0.55) PDE3BPDE3AKDM4EALDH1A1MEN1
SCHEMBL7386282 0.82 PDE3B (0.72) PDE3BPDE3A
SCHEMBL7382885 0.80 PDE3B (0.72) PDE3BPDE3A
SCHEMBL7377905 0.80 PDE3B (0.64) PDE3BPDE3AKDM4EALDH1A1MEN1
SCHEMBL7377041 0.79 PDE3B (0.76) PDE3BPDE3AADORA2AADORA1
Hydrochloric Acid SCHEMBL7385661 0.79 PDE3B (0.70) PDE3BPDE3A
SCHEMBL23242456 0.79 ALDH1A1 (0.47) XDHADORA2AADORA1KDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4963561-A Phosphodiesterase inhibitors STERLING DRUG INC. (US) 1990-10-16 US claimed
US-5010086-A Enzyme inhibitor for treating congestive heart failure or hypertension in mammals STERLING DRUG INC. (US) 1991-04-23 US disclosed
US-4963561-A Phosphodiesterase inhibitors STERLING DRUG INC. (US) 1990-10-16 US disclosed